AC Immune SA to Receive Milestone Payment For Anti Tau Antibody Moving Into Phase 2 Trial For Alzheimer s Disease

Thursday, November 2, 2017 1 min read

Key Takeaway: AC Immune SA to Receive Milestone Payment For Anti Tau Antibody Moving Into Phase 2 Trial For Alzheimer s Disease

Full Press Release Details

AC Immune SA to Receive Milestone Payment For Anti Tau Antibody Moving Into Phase 2 Trial For Alzheimer s Disease.